
Amvissa Pharmaceuticals Private Limited
About Amvissa Pharmaceuticals Private Limited
Data last updated:
Amvissa Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 04 January 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC229641. Its GSTIN is 10AAKCA1523D1ZJ (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Veena Kumari and Vinay Krishna.
Its last annual general meeting (AGM) was held on 31 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 407 Puneet Apartment B – 10 Vasundhra Enclave, New Delhi, Delhi, India – 110096.
As per the financials filed for FY 2017, the company reported a revenue of ₹5.02 Lakh. For the same year it recorded a net loss of ₹1.71 Lakh (net margin -34%) and EBITDA of -₹1.61 Lakh (EBITDA margin -32.1%).
The company is associated with 1 brand: Amvissa Pharmaceuticals.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Amvissa Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA 407 Puneet Apartment B – 10 Vasundhra Enclave, New Delhi, Delhi, India – 110096
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Amvissa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Amvissa Pharmaceuticals operates one associated brand: Amvissa Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality finished pharmaceutical formulations. | amvissa.com |
Business activity
The main business activity of Amvissa Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Amvissa Pharmaceuticals Private Limited, buy the company report.
Financials of Amvissa Pharmaceuticals Private Limited
FY 2025 filings availableAmvissa Pharmaceuticals Private Limited reported revenue of ₹5.02 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹5.02 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.61 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.71 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -32.1% | ||
| Net Profit Margin | -34% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Amvissa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Amvissa Pharmaceuticals Private Limited
Amvissa Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veena Kumari | Director | 04 Jan 2012 | 14 Years 9 Months | Current |
| Vinay Krishna | Director | 04 Jan 2012 | 14 Years 9 Months | Current |
Auditor
Amvissa Pharmaceuticals Private Limited is audited by S B SHARMA & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S B SHARMA & ASSOCIATES | FY 2017 | 016096C |
Shareholding
The shareholding of Amvissa Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Amvissa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Amvissa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amvissa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amvissa Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAKCA1523D1ZJ | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amvissa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Amvissa Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Veena Kumari was appointed as Director on 04 Jan 2012.
Frequently asked questions
Amvissa Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other hospital and medical care activities, within the healthcare industry. It was incorporated on 04 January 2012 (14+ years old) and is registered under CIN U24232DL2012PTC229641.
Amvissa Pharmaceuticals has 2 current directors:
- Veena Kumari - Director
- Vinay Krishna - Director
The latest financial statements of Amvissa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 August 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Amvissa Pharmaceuticals is 10AAKCA1523D1ZJ, registered in Bihar.
The CIN (Corporate Identification Number) of Amvissa Pharmaceuticals is U24232DL2012PTC229641. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amvissa Pharmaceuticals was incorporated on 04 January 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Veena Kumari was appointed as Director on 04 Jan 2012. Vinay Krishna was appointed as Director on 04 Jan 2012.
The registered office of Amvissa Pharmaceuticals is at A 407 Puneet Apartment B – 10 Vasundhra Enclave, New Delhi, Delhi, India – 110096.
Amvissa Pharmaceuticals operates in the healthcare industry, in the other hospital and medical care activities segment.
The compliance status of Amvissa Pharmaceuticals is active non-compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.